Placental site trophoblastic tumour mimicking an intramural pregnancy: a case report and review of the literature.
gestational trophoblastic disease
placental site trophoblastic tumour
prognosis
treatment
Journal
Przeglad menopauzalny = Menopause review
ISSN: 1643-8876
Titre abrégé: Prz Menopauzalny
Pays: Poland
ID NLM: 101263235
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
09
11
2021
accepted:
05
02
2022
entrez:
6
10
2022
pubmed:
7
10
2022
medline:
7
10
2022
Statut:
ppublish
Résumé
Gestational trophoblastic disease (GTD) covers a range of proliferative disorders from non-neoplastic hydatid moles to malignant neoplastic conditions such as choriocarcinoma. The incidence of these diseases is low and often challenging to diagnose. Placental site trophoblastic tumour (PSTT) is the rarest form of GTD, accounting for up to 3% of all cases. We present a case of a 35-year-old patient diagnosed with PSTT mimicking an intramural pregnancy. Placental site trophoblastic tumour occurred after pregnancy, which ended as a blighted ovum. β-hCG was not very high, and the patient had no complaints. The diagnosis was made after resection of formation which was accepted for intramural pregnancy. To our knowledge, this is the first such case described in the literature. A hysterectomy performed later confirmed the absence of a residual tumour after conservative intervention. The lack of distant metastases, confirmed by positron emission tomography-computed tomography scan, allowed for only hysterectomy with bilateral salpingo-oophorectomy to be performed. The patient was classified as low risk according to the World Health Organization (WHO) scoring system. Placental site trophoblastic tumour is a rare malignant tumour (despite its WHO coding) from the group of GTDs. It is not presented with a classic clinical picture, and its clinical diagnosis is challenging. However, clinicians should consider it in the case of unclear events after any type of pregnancy.
Identifiants
pubmed: 36199742
doi: 10.5114/pm.2022.116502
pii: 47093
pmc: PMC9528820
doi:
Types de publication
Case Reports
Langues
eng
Pagination
142-147Informations de copyright
Copyright © 2022 Termedia.
Déclaration de conflit d'intérêts
The authors report no conflict of interest.
Références
Lancet. 2009 Jul 4;374(9683):48-55
pubmed: 19552948
Int J Gynecol Pathol. 2001 Jan;20(1):31-47
pubmed: 11192071
Geburtshilfe Frauenheilkd. 2015 Oct;75(10):1043-1050
pubmed: 26556906
Curr Treat Options Oncol. 2017 Aug 24;18(10):58
pubmed: 28840513
Ultrasound Obstet Gynecol. 2013 Jun;41(6):679-84
pubmed: 22807194
Obstet Gynecol Surv. 2003 Jul;58(7):484-8
pubmed: 12832940
Nat Clin Pract Oncol. 2008 Mar;5(3):171-5
pubmed: 18227827
Lancet. 2010 Aug 28;376(9742):717-29
pubmed: 20673583
BJOG. 2012 Feb;119(3):369-74; discussion 374
pubmed: 22168173
Arch Pathol Lab Med. 2019 Jan;143(1):65-74
pubmed: 30407075
Front Surg. 2014 Aug 27;1:31
pubmed: 25593955
Medicine (Baltimore). 2018 Nov;97(48):e13439
pubmed: 30508960
Ann Oncol. 2013 Oct;24 Suppl 6:vi39-50
pubmed: 23999759
Gynecol Oncol. 2004 Feb;92(2):708-12
pubmed: 14766272
Gynecol Oncol Rep. 2020 Feb 13;32:100548
pubmed: 32274412
Med J Armed Forces India. 2013 Jan;69(1):68-70
pubmed: 24532939
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:79-85
pubmed: 30306586
Int J Clin Oncol. 2008 Jun;13(3):263-5
pubmed: 18553238
Gynecol Oncol. 2017 Jan;144(1):208-214
pubmed: 27789086
Eur J Gynaecol Oncol. 2006;27(6):545-51
pubmed: 17290581
Gynecol Oncol. 2005 Oct;99(1):239-42
pubmed: 16051337
Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S109-16
pubmed: 25341573
Gynecol Oncol. 2005 Dec;99(3):603-7
pubmed: 16085293
Gynecol Oncol. 2010 Mar;116(3):430-7
pubmed: 19910023
J Reprod Med. 2002 Jun;47(6):460-4
pubmed: 12092014
J Postgrad Med. 2002 Jul-Sep;48(3):211-2
pubmed: 12432200
APMIS. 2018 Jul;126(7):647-654
pubmed: 30129126
Gynecol Oncol. 2013 Apr;129(1):58-62
pubmed: 23274560